Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Recent news

| | share

Congratulations to our 2026 Leadership and Development Awardees

In late June, the Selection Panel selected this year’s 7 new Leadership and Development Awardees. We are pleased to announce that we have a broad range of members from different backgrounds in endocrinology.

Discontinuation of Quinagolide statement

Members should be aware that quinagolide tablets have been discontinued in the UK.

Permanent discontinuation of macimorelin statement 

Members should be aware that Pharmanovia has confirmed the permanent discontinuation of macimorelin due to manufacturing issues.